Health implications of creatine: Can oral creatine supplementation protect against neurological and atherosclerotic disease?

Neuroscience

Volumn 112, Issue 2, 2002, Pages 243-260

  Wyss, Markus ^a   Schulze, Andreas ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

AGAT deficiency; Creatine supplementation; Creatine transporter deficiency; GAMT deficiency; Hyperhomocysteinemia; Neurological disease

Indexed keywords

CREATINE; CREATINE KINASE; CREATINE PHOSPHATE; CREATINE TRANSPORTER; GLYCINE AMIDINOTRANSFERASE; HOMOCYSTEINE; ISOENZYME; METHYLTRANSFERASE; S ADENOSYLMETHIONINE:N GUANIDINOACETATE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; BEHAVIOR DISORDER; BIOSYNTHESIS; BRAIN ATHEROSCLEROSIS; BRAIN FUNCTION; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; ENZYME DEFICIENCY; ENZYME LOCALIZATION; ENZYME MECHANISM; HUMAN; HUNTINGTON CHOREA; INBORN ERROR OF METABOLISM; INTELLIGENCE; ISCHEMIC HEART DISEASE; KNOCKOUT MOUSE; LEARNING DISORDER; LIFE EXPECTANCY; LIPID METABOLISM; MEMORY; MENTAL DEFICIENCY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANIMALS; ARTERIOSCLEROSIS; CREATINE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; METABOLISM, INBORN ERRORS; NERVOUS SYSTEM DISEASES;

EID: 0037129967     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00088-X     Document Type: Review

References (147)

1. Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease
2. Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation
3. Therapeutic comparison of metformin and creatine in the glycemic control of patients with type 2 diabetes mellitus
4. Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: Dose-effect relationship
5. Inadvertent doping through supplement use by athletes: Assessment and management of the risk in Australia
6. Is there a rationale for the use of creatine either as nutritional supplementation or drug administration in humans participating in a sport?
7. Creatine as nutritional supplementation and medicinal product
8. Effects of creatine monohydrate ingestion in sedentary and weight-trained older adults
9. Transport of energy in muscle: The phosphorylcreatine shuttle
10. Reversible brain creatine deficiency in two sisters with normal blood creatine level
11. Glycolysis supports calcium uptake by the sarcoplasmic reticulum in skinned ventricular fibres of mice deficient in mitochondrial and cytosolic creatine kinase
12. Moderate hyperhomocysteinaemia and vascular disease: Evidence, relevance and the effect of treatment
13. Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies
14. Endogenous synthesis and transport of creatine in the rat brain: An in situ hybridization study
15. Protective effect of the energy precursor creatine against toxicity of glutamate and β-amyloid in rat hippocampal neurons
16. On the mechanisms of neuroprotection by creatine and phosphocreatine
17. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins
18. Automated high-performance liquid chromatographic method for the determination of guanidinoacetic acid in dried blood spots: A tool for early diagnosis of guanidinoacetate methyltransferase deficiency
19. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels
20. The clinical syndrome of creatine transporter deficiency
21. Irreversible brain creatine deficiency with elevated serum and urine creatine: A creatine transporter defect?
22. Sur la composition chimique du bouillon de viandes
23. The mitochondrial permeability transition pore and its role in cell death
24. Changes in glycolytic network and mitochondrial design in creatine kinase-deficient muscles
25. Increase of total creatine in human brain after oral supplementation of creatine-monohydrate
26. 2+ exchanger
27. Factors explaining the difference of total homocysteine between men and women in the European investigation into cancer and nutrition Potsdam study
28. Creatine monohydrate does not increase strength in patients with hereditary neuropathy
29. Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle
30. Creatine supplementation increases renal disease progression in Han:SPRD-cy rats
31. The inorganic phopshate and a labile form of organic phosphate in the gastrocnemius of the frog
32. Presence of muscle creatine in a patient with guanidinoacetate methyltransferase (GAMT) deficiency
33. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease
34. The nature of the 'inorganic phosphate' in voluntary muscle
35. Guanidinoacetate methyltransferase deficiency: New clinical features
36. Murine muscles deficient in creatine kinase tolerate repeated series of high-intensity contractions
37. Creatine: A review of efficacy and safety
38. Pyruvate protects against 3-nitropropionic acid neurotoxicity in corticostriatal slice cultures
39. Creatine supplementation patterns and perceived effects in select division I collegiate athletes
40. Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo down-regulation of the expression of creatine transporter isoforms in skeletal muscle
41. Homocysteine and vascular disease
42. 31P spectrum in gyrate atrophy with hyperornithinaemia
43. Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans
44. Creatine supplementation: exploring the role of the creatine kinase/phosphocreatine system in human muscle
45. In vivo development of brain phosphocreatine in normal and creatine-treated rabbit pups
46. Brain creatine phosphate and creatine kinase in mice fed an analogue of creatine
47. Creatine increases survival and suppresses seizures in the hypoxic immature rat
48. Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse
49. Arginine:glycine amidinotransferase deficiency: The third inborn error of creatine metabolism in humans
50. Oral creatine supplementation enhances upper extremity work capacity in persons with cervical-level spinal cord injury
51. Nutrition practices and knowledge of college varsity athletes: A follow-up
52. Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement
53. Oral creatine supplementation in male collegiate athletes: A survey of dosing habits and side effects
54. Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype
55. Direct evidence for the control of mitochondrial respiration by mitochondrial creatine kinase in oxidative muscle cells in situ
56. Altered brain phosphocreatine and ATP regulation when mitochondrial creatine kinase is absent
57. Placebo-controlled trial of creatine in Huntington's disease
58. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
59. A placebo-controlled crossover trial of creatine in mitochondrial diseases
60. Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons
61. Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis
62. Interstitial nephritis in a patient taking creatine
63. Effects of creatine supplementation on body composition, strength, and sprint performance
64. Creatine supplement use in an NCAA division I athletic program
65. Synthesis and biological activity of analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid: Discovery of a novel aminoguanidinoacetic acid antidiabetic agent
66. Direct antioxidant properties of creatine
67. Brain creatine depletion: Guanidinoacetate methyltransferase deficiency (improving with creatine supplementation)
68. Über die enzymatische Aufspaltung der Kreatinphosphorsäure; Zugleich ein Beitrag zum Chemismus der Muskelkontraktion
69. Weitere Untersuchungen über Muskelkontraktionen ohne Milchsäurebildung
70. Plasma total homocysteine in healthy subjects: Sex-specific relation with biological traits
71. Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton
72. Neuroprotective effects of creatine administration against NMDA and malonate toxicity
73. Formation of PhIP in a mixture of creatinine, phenylalanine and sugar or aldehyde by aqueous heating
74. Neurotoxicity of glutamate uptake inhibition in vivo: Correlation with succinate dehydrogenase activity and prevention by energy substrates
75. Creatine and cyclocreatine attenuate MPTP neurotoxicity
76. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease
77. Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: Preliminary results
78. Supplemental creatine may decrease serum homocysteine and abolish the homocysteine 'gender gap' by suppressing endogenous creatine synthesis
79. Creatine supplementation in high school football players
80. Health assessment of creatine as a dietary supplement (in German)
81. Creatine use among young athletes
82. Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women
83. Hyperhomocyst(e)inemia induces multiorgan damage
84. Labile methyl group balances in the human: The role of sarcosine
85. Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithenemia
86. Does supplemental creatine prevent herpes recurrences?
87. Manipulating creatine levels post-myocardial infarction - chronic effects on left ventricular remodeling
88. Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice
89. Clinical pharmacology of the dietary supplement creatine monohydrate
90. Effect of short-term creatine supplementation on renal responses in men
91. Long-term oral creatine supplementation does not impair renal function in healthy athletes
92. Adverse effects of creatine supplementation: Fact or fiction?
93. Renal dysfunction accompanying oral creatine supplements
94. 31P NMR
95. Compromised energetics in the adenylate kinase AK1 gene knockout heart under metabolic stress
96. Homocysteine concentrations in a German cohort of 500 individuals: Reference ranges and determinants of plasma levels in healthy children and their parents
97. Use of oral creatine as an ergogenic aid for increased sports performance: Perceptions of adolescent athletes
98. Acute quadriceps compartment syndrome and rhabdomyolysis in a weight lifter using high-dose creatine supplementation
99. Dietary creatine supplementation does not affect some haematological indices, or indices of muscle damage and hepatic and renal function
100. Role of creatine phosphokinase in cellular function and metabolism
101. X-linked creatine transporter defect: The first two families
102. X-linked creatine-transporter gene (SLC6A8) defect: A new creatine-deficiency syndrome
103. Creatine supplementation and health variables: A retrospective study
104. Creatine-deficiency syndromes
105. Improving treatment of guanidinoacetate methyltransferase deficiency: Reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation
106. Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: Diagnostic tools for a new inborn error of metabolism
107. Therapeutic trial of arginine restriction in creatine deficiency syndrome
108. Homocysteine metabolism
109. Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats
110. LCHAD deficiency treated with creatine
111. Creatine use among a select population of high school athletes
112. Creatine and the creatine transporter: A review
113. Methylation demand and homocysteine metabolism: Effects of dietary provision of creatine and guanidinoacetate
114. Use of gene targeting for compromising energy homeostasis in neuromuscular tissues: The role of sarcomeric mitochondrial creatine kinase
115. Mice deficient in ubiquitous mitochondrial creatine kinase are viable and fertile
116. The effect of creatine and resistance training on plasma homocysteine concentration in healthy volunteers
117. Creatine deficiency in the brain: A new, treatable inborn error of metabolism
118. Effects of resistance exercise and creatine supplementation on myasthenia gravis: A case study
119. Dietary supplement creatine protects against traumatic brain injury
120. Potential benefits of creatine monohydrate supplementation in the elderly
121. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders
122. Creatine monohydrate increases strength in patients with neuromuscular disease
123. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies
124. The physiological and health effects of oral creatine supplementation
125. Metabolite channeling: A phosphorylcreatine shuttle to mediate high energy phosphate transport between sperm mitochondrion and tail
126. Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia
127. Synthesis and biological activity of aminoguanidine and diaminoguanidine analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid
128. Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia
129. Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity
130. Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect
131. No effect of heavy resistance training and creatine supplementation on blood lipids
132. Guanidinoacetate methyltransferase deficiency
133. Creatine therapy in myophosphorylase deficiency (McArdle disease). A placebo-controlled crossover trial
134. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study
135. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation
136. Myofibrillar or mitochondrial creatine kinase deficiency alone does not impair mouse diaphragm isotonic function
137. Mechanisms of disease: Homocysteine and atherothrombosis
138. Coupling between the CK pathway and other networks for high-energy phosphoryl (ATP) transfer in mammalian cells
139. Creatine protects the central respiratory network of mammals under anoxid conditions
140. Anoxic ATP depletion in neonatal mice brainstem is prevented by creatine supplementation
141. Effects of oral creatine supplementation on maximal pedalling performance in older adults
142. The therapeutic potential of oral creatine supplementation in muscle disease
143. Creatine and creatinine metabolism
144. Potential cytotoxic effect of chronic administration of creatine, a nutrition supplement to augment athletic performance
145. Adenylate kinase-catalyzed phosphoryl transfer couples ATP utilization with its generation by glycolysis in intact muscle